NinePoint Medical, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2015 | $31 M | No. 3 | $10 to $50 million | equity | SEC | |
| Mar 2014 | $35 M | No. 2 | $10 to $50 million | equity | SEC | |
| Sep 2009 | $5 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
NinePoint Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2015).
SEC Form D · Nov 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Nov 2015
That is all the official record says: NinePoint Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: its website does not allow automated readers.
Investors#
No investor of NinePoint Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 3 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Christopher von Jako | Executive officer | Nov 2015 |
| Charles Carignan | Executive officer | Mar 2014 |
| Judith M. Huber | Executive officer | Mar 2014 |
| Kevin Gillis | Executive officer | Oct 2009 |
| Mark Levin | Executive officer | Oct 2009 |
| Mitchell Bloom | Executive officer | Oct 2009 |
| Christopher von Jako | Director | Nov 2015 |
| Curt J. Weinstein | Director | Nov 2015 |
| Eric Swanson | Director | Nov 2015 |
| Henry J. Lee | Director | Nov 2015 |
| Mark J. Stautberg | Director | Nov 2015 |
| Mark Levin | Director | Nov 2015 |
| Russell Hirsch | Director | Nov 2015 |
| Scott J. Gazelle | Director | Nov 2015 |
| Thomas J. Miller | Director | Nov 2015 |
| Charles Carignan | Director | Mar 2014 |
| Curt M. Weinstein | Director | Mar 2014 |
| Mark M. Stautberg | Director | Mar 2014 |
About
Company in Bedford, United States.